Antiganglioside antibodies in neurological diseases
Gangliosides are sialylated glycosphingolipids, highly abundant in our nervous system. Antibodies targeting gangliosides are usually developed as a consequence of molecular mimicry following infections. Antiganglioside antibodies are implicated in many neurological disorders such as acute and chronic polyradiculoneuropathies which includes different variants of Guillain-Barr é syndrome, chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy. Presence of such antibodies in paraneoplastic peripheral neuropathy, neurodegenerative disorders, multiple sclerosis, myasthenia gravis and amyotrophic lateral sclerosis have also been reported.
Source: Journal of the Neurological Sciences - Category: Neurology Authors: Pitchaya Wanleenuwat, Piotr Iwanowski, Wojciech Kozubski Tags: Review Article Source Type: research
More News: ALS | Brain | CIDP | Guillain-Barr Syndrome | Multiple Sclerosis | Myasthenia Gravis | Neurology | Paraneoplastic Syndrome | Peripheral Neuropathy